| Title : Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial) - Stam_2018_BMJ.Open_8_e019932 |
| Author(s) : Stam M , Wadman RI , Wijngaarde CA , Bartels B , Asselman FL , Otto LAM , Goedee HS , Habets LE , de Groot JF , Schoenmakers M , Cuppen I , van den Berg LH , van der Pol WL |
| Ref : BMJ Open , 8 :e019932 , 2018 |
| Abstract : Stam_2018_BMJ.Open_8_e019932 |
| ESTHER : Stam_2018_BMJ.Open_8_e019932 |
| PubMedSearch : Stam_2018_BMJ.Open_8_e019932 |
| PubMedID: 30061431 |
Stam M, Wadman RI, Wijngaarde CA, Bartels B, Asselman FL, Otto LAM, Goedee HS, Habets LE, de Groot JF, Schoenmakers M, Cuppen I, van den Berg LH, van der Pol WL (2018)
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial)
BMJ Open
8 :e019932
Stam M, Wadman RI, Wijngaarde CA, Bartels B, Asselman FL, Otto LAM, Goedee HS, Habets LE, de Groot JF, Schoenmakers M, Cuppen I, van den Berg LH, van der Pol WL (2018)
BMJ Open
8 :e019932